| PT provider |
AOAC International
AOAC International
|
| Based in |
United States
|
| Language(s) |
English
|
| Remarks |
|
| Product groups |
Agriculture
|
| Testing fields |
Analytical chemistry
|
| Test item |
Tested property |
Testing method |
| Cannabis |
Abamectin (Avermectins: B1a & B1b)
|
User Specified |
|
Acephate
|
User Specified |
|
Acequinocyl
|
User Specified |
|
Acetamiprid
|
User Specified |
|
Aldicarb
|
User Specified |
|
Allethrin
|
User Specified |
|
Ancymidol
|
User Specified |
|
Azadirachtin
|
User Specified |
|
Azoxystrobin
|
User Specified |
|
Benzovindiflupyr
|
User Specified |
|
Bifenazate
|
User Specified |
|
Bifenthrin
|
User Specified |
|
Boscalid
|
User Specified |
|
Buprofezin
|
User Specified |
|
Captan
|
User Specified |
|
Carbaryl
|
User Specified |
|
Carbofuran
|
User Specified |
|
Chlorantraniliprole
|
User Specified |
|
Chlordane
|
User Specified |
|
Chlorfenapyr
|
User Specified |
|
Chlormequat chloride
|
User Specified |
|
Chlorpyrifos
|
User Specified |
|
Clofentezine
|
User Specified |
|
Clothianidin
|
User Specified |
|
Coumaphos
|
User Specified |
|
Cyantraniliprole
|
User Specified |
|
Cyfluthrin (Baythroid)
|
User Specified |
|
Cypermethrin
|
User Specified |
|
Cyprodinil
|
User Specified |
|
Daminozide
|
User Specified |
|
Deltamethrin
|
User Specified |
|
Diazinon
|
User Specified |
|
Dichlorvos
|
User Specified |
|
Dimethoate
|
User Specified |
|
Dimethomorph
|
User Specified |
|
Dinotefuran
|
User Specified |
|
Dodemorph
|
User Specified |
|
Endosulfan I (alpha)
|
User Specified |
|
Endosulfan II (beta)
|
User Specified |
|
Endosulfan sulfate
|
User Specified |
|
Ethephon
|
User Specified |
|
Ethoprophos (Prophos)
|
User Specified |
|
Etofenprox
|
User Specified |
|
Etoxazole
|
User Specified |
|
Etridiazole (Terrazole)
|
User Specified |
|
Fenhexamid
|
User Specified |
|
Fenoxycarb
|
User Specified |
|
Fenpyroximate (mix of isomers)
|
User Specified |
|
Fensulfothion
|
User Specified |
|
Fenthion
|
User Specified |
|
Fenvalerete (Sanmarton)
|
User Specified |
|
Fipronil
|
User Specified |
|
Flonicamid
|
User Specified |
|
Fludioxonil
|
User Specified |
|
Fluopyram
|
User Specified |
|
Flurprimidol
|
User Specified |
|
Hexythiazox
|
User Specified |
|
Imazalil
|
User Specified |
|
Imidacloprid
|
User Specified |
|
Iprodione
|
User Specified |
|
Kinoprene
|
User Specified |
|
Kresoxim-methyl
|
User Specified |
|
Malathion
|
User Specified |
|
Metalaxyl
|
User Specified |
|
Methoprene
|
User Specified |
|
Methyl parathion
|
User Specified |
|
Mevinphos
|
User Specified |
|
MGK-264
|
User Specified |
|
Myclobutanil
|
User Specified |
|
Naled (Systhane) (Dibrom)
|
User Specified |
|
Novaluron
|
User Specified |
|
Oxamyl
|
User Specified |
|
Paclobutrazol
|
User Specified |
|
Pentachloronitrobenzene (Quintozene)
|
User Specified |
|
Permethrin (mix of isomers)
|
User Specified |
|
Phenothrin (d-phenothrin)
|
User Specified |
|
Phosmet (Imidan)
|
User Specified |
|
Phosmet (oxon)
|
User Specified |
|
Piperonyl butoxide
|
User Specified |
|
Pirimicarb
|
User Specified |
|
Prallethrin (mix of isomers)
|
User Specified |
|
Propiconazole (tilt)
|
User Specified |
|
Propoxur (Baygon)
|
User Specified |
|
Pyraclostrobin
|
User Specified |
|
Pyrethrin (mix of isomers)
|
User Specified |
|
Pyridaben
|
User Specified |
|
Resmethrin
|
User Specified |
|
Spinetoram
|
User Specified |
|
Spinosad (mixture of A and D)
|
User Specified |
|
Spirodiclofen
|
User Specified |
|
Spiromesifen
|
User Specified |
|
Spirotetramat
|
User Specified |
|
Spiroxamine
|
User Specified |
|
Tebuconazole
|
User Specified |
|
Tebufenozide
|
User Specified |
|
Teflubenzuron
|
User Specified |
|
Tetrachlorvinphos
|
User Specified |
|
Tetramethrin
|
User Specified |
|
Thiacloprid
|
User Specified |
|
Thiamethoxam
|
User Specified |
|
Thiophanate-methyl
|
User Specified |
|
Trifloxystrobin
|
User Specified |
|
Ochratoxin A
|
User Specified |
|
Aflatoxin B1
|
User Specified |
|
Aflatoxin B2
|
User Specified |
|
Aflatoxin G1
|
User Specified |
|
Aflatoxin G2
|
User Specified |
|
| Target group of participants |
Hemp and Cannabis Laboratories. Geographical restrictions can occur based on individual country.
|
| Linked to specific legislation / standards |
|
| Additional, subsidiary aims |
|
| Number of participants |
|
| Accredited or otherwise reviewed by a 3rd party |
Accredited by
A2LA
on the basis of
ISO/IEC17043:2023
|
| Operation is commissioned / requested by |
|
| Participation fee |
$1,225 + Shipping
|
| Regularly operated |
Yes
(March and September)
|
| Year of first operation |
|
|
Provider
|
Contact person
|
AOAC International
P.O. Box 1067
20849-1067 Rockvile, Md.
United States
Phone:
+1-301-924-7077 option 2
Fax:
Web:
http://www.aoac.org
http://www.aoac.org
|
Senior Director PT Programs Shane Flynn
Phone:
+1-301-924-7077 option 2
Fax:
Email:
sflynn@aoac.org
sflynn@aoac.org
|
